SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2022 on August 9, 2022
July 14 2022 - 7:00AM
SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven
medicine, today announced it will release its financial
results for the second quarter of fiscal 2022 before U.S. markets
open on Tuesday, August 9, 2022. SOPHiA GENETICS will host a
conference call to discuss its financial results as well as
business outlook beginning at 8:30 a.m. EDT / 2:30 p.m. CEST.
The call will be webcast live on the SOPHiA GENETICS Investor
Relations website. Additionally, a replay will be available on the
website after its completion.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology
company dedicated to establishing the practice of data-driven
medicine as the standard of care and for life sciences research. It
is the creator of the SOPHiA DDM™ Platform, a cloud-based platform
capable of analyzing data and generating insights from complex
multimodal data sets and different diagnostic modalities. The
SOPHiA DDM™ Platform and related solutions, products and services
are currently used by over 790 hospital, laboratory, and biopharma
institutions globally. For more information, visit
SOPHiAGENETICS.COM, or connect on Twitter, LinkedIn and Instagram.
Where others see data, we see answers.
Investor Contact:Jennifer PottageHead of
Investor RelationsJpottage@sophiagenetics.com
Media Contact:Don GranesePublic
RelationsDgranese@sophiagenetics.com
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Oct 2023 to Oct 2024